Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €6.2→€7 | ― | 1.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €35.11 | ― | 19.20% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €3→€3.4 | ― | 21.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €27.4 | ― | 20.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €9.7→€9 | ― | 8.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €18.5→€19.5 | ― | 3.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €13.5→€14 | ― | 7.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €13.9 | ― | 36.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €4.5→€5 | ― | 4.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €14.5 | ― | 15.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €31 | ― | 8.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €7.2 | ― | 16.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €5.8→€5.9 | ― | 4.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €83→€88 | ― | 1.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €28.08→€26.24 | ― | 11.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €35→€42 | ― | 20.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €38 | ― | 21.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €3.3 | ― | 8.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €28.9 | ― | 8.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €10 | ― | 8.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €150→€153 | ― | 8.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €1.84 | ― | 16.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL €0.35 | ― | 16.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €13 | ― | 16.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €2 | ― | 34.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €16.4→€16.9 | ― | 34.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €14.2→€14.8 | ― | 9.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €6.8→€7.1 | ― | 34.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €5 | ― | 16.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €39.3→€37 | ― | 11.90% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €2.3 | ― | 8.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD €3.9 | ― | 12.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €51 | ― | 34.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY €6 | ― | 5.00% | Reiterated | ||||
Italian Sea Group S.p.A. | BUY €12.5 | ― | -0.40% | Reiterated | |||||
Fine Foods & Pharmaceuticals N.T.M. SpA | BUY €12 | ― | -0.60% | Reiterated | Analysts Are Bullish on Top Consumer Goods Stocks: Sodexo SA (GB:0J3F), Fine Foods & Pharmaceuticals N.T.M. SpA (IT:FF) | ||||
CY4Gate SpA | BUY €8.7 | ― | -6.50% | Reiterated | We are leaving our estimates unchanged, still projecting revenues at Eu85mn (including a ~Eu5mn contribution from the consolidation of XTN in January), with the adj. EBITDA margin returning to 2022 levels (30%). BUY; target €8.70 confirmed: in 2024, CY4 aims to expand its corporate client base, tapping into opportunities in defence and cybersecurity, and to improve business seasonality (high amount of revenue and cash-in skewed towards the last part of the year). While M&A remains a key growth driver, we do not expect this to occur in the short term. At this stage, we believe delivery on financial targets and the announcement of new contracts remain crucial for a stock re-rating. On the back of unchanged estimates, we confirm our BUY rating and target price of €8.70. | ||||
Somec S.p.A. | HOLD €18 | ― | -2.50% | Reiterated | |||||
SNAM S.p.A. | BUY €5.1 | ― | -3.60% | Reiterated | |||||
Lottomatica Group S.P.A. | BUY €13 | ― | -5.40% | Reiterated | |||||
FinecoBank SpA | BUY €16.3→€16.8 | ― | -0.40% | Reiterated | FinecoBank (FBK:IM) (FCBBF) PT Raised to EUR16.80 at JPMorganJPMorgan analyst Enrico Bolzoni raised the price target on FinecoBank (FBK:IM) (OTC: FCBBF) to EUR16.80 (from EUR16.30) while maintaining a Overweight rating. | ||||
Aquafil SpA | BUY €4.5 | ― | -21.40% | Reiterated | |||||
BFF Bank SpA | BUY €16→€12 | ― | -1.60% | Reiterated | BFF Bank SpA (BFF:IM) PT Lowered to EUR12 at JefferiesJefferies analyst Julian Roberts lowered the price target on BFF Bank SpA (BFF:IM) to EUR12.00 (from EUR16.00) while maintaining a Buy rating. | ||||
Tinexta SpA | BUY €25 | ― | -1.60% | Reiterated | We stress that the Business Innovation segment is usually characterised by a strong seasonal effect (with revenue generation mainly concentrated in 4Q). Moreover, this trend was further accentuated, mainly due to: i) a ‘wait-and-see’ approach related to the reduction in the rates relating to the recent approval of the new 5.0 transition plan in Italy, which should support demand from the second half of the year; and ii) the consolidation of ABF Group in France, which further increased the seasonality of the business, as the company's 1Q sales weighted at around 5% of total FY sales. We left unchanged for now our 2024-26 estimates, broadly aligned with management’s guidance. TP and recommendation confirmed. | ||||
SECO S.p.A. | HOLD €4.2→€4.1 | ― | -1.40% | Reiterated | We fine-tuned our FY24-26E EPS, reflecting 1Q24 release and the messages on the outlook. In FY24E we are now assuming a flat YoY top-line growth (from previous +5% YoY), mainly reflecting a weaker 1H24E to be followed by a mid-teens growth pace in 2H24E supported by underlying demand recovery. We slightly improved our assumptions on profitability, anticipating an adj. EBITDA margin of 24.5% in FY24E (+40bps YoY) driven by better GPM, while we slightly reduce our FCF forecasts to €16m (from €18m), factoring in higher absorption from NWC. Going forward, we broadly confirm our mid-teens sales CAGR in FY25-26E to be driven by demand recovery and higher penetration of CLEA, with growing volumes and favourable mix to support ~50bps/year of EBITDA margin expansion. | ||||
Esprinet Spa | BUY €6.5 | ― | -6.50% | Reiterated | We are reducing our estimates for FY24 to the mid-point of the guidance, implementing a similar revision to our FY25-26 estimates, while keeping our forecast cash-flow unchanged, as the company is showing it has a firm grip on WC management. | ||||
OVS S.p.A. | BUY €2→€2.8 | ― | -2.50% | Reiterated | |||||
Stellantis | BUY €30 | ― | -2.20% | Reiterated | Analysts' Opinions Are Mixed on These Consumer Cyclical Stocks: Trigano SA (Other OTC: TGNOF), Stellantis (NYSE: STLA) and lastminute (Other OTC: LSMNF) | ||||
Iren S.p.A. | HOLD €1.9 | ― | -3.60% | Reiterated | |||||
Nexi S.p.A. | BUY €9 | ― | -4.30% | Reiterated |